Cargando…
T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis
Pre-exposure prophylaxis (PrEP) with anti-viral drugs is currently in clinical trials for the prevention of HIV infection. Induction of adaptive immune responses to virus exposures during anti-viral drug administration, i.e., a “chemo-vaccination” effect, could contribute to PrEP efficacy. To study...
Autores principales: | Kersh, Ellen N., Adams, Debra R., Youngpairoj, Ae S., Luo, Wei, Zheng, Qi, Cong, Mian-er, Aung, Wutyi, Mitchell, James, Otten, Ron, Hendry, R. Michael, Heneine, Walid, McNicholl, Janet, Garcia-Lerma, J. Gerardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082568/ https://www.ncbi.nlm.nih.gov/pubmed/21541293 http://dx.doi.org/10.1371/journal.pone.0019295 |
Ejemplares similares
-
Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs
por: Cong, Mian-er, et al.
Publicado: (2016) -
Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis
por: Zheng, Qi, et al.
Publicado: (2012) -
Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV
por: Garber, David A., et al.
Publicado: (2018) -
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
por: Radzio-Basu, Jessica, et al.
Publicado: (2019) -
Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir
por: García-Lerma, J. Gerardo, et al.
Publicado: (2008)